Clinical Trial Search Results for "TIMI 10B"

Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation. 1998;98:2805-14. Abstract

Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. Am Heart J. 1999;137:1179-84. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Adgey, A. A., Schweiger, M. J., Sequeira, R. F., Grollier, G., Fox, N. L., Berioli, S., Weaver, W. D., Van de Werf, F., Braunwald, E. Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators Am J Cardiol. 1999;84(9):976-80. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Braunwald, E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B J Am Coll Cardiol. 1999;34(3):739-47. Abstract

Barron, H. V., Cannon, C. P., Murphy, S. A., Braunwald, E., Gibson, C. M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy Circulation. 2000;102(19):2329-34. Abstract

Gibson, C. M., Anshelevich, M., Murphy, S., Luu, L., Hynes, C., Kliris, J., Kermgard, S., Otten, M. H., Antman, E. M., Cannon, C. P., Braunwald, E. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction Am J Cardiol. 2000;86(12):1378-9, A5. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Ryan, K. A., Mesley, R., Marble, S. J., McCabe, C. H., Van De Werf, F., Braunwald, E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation. 2000;101(2):125-30. Abstract

Modi, N. B., Fox, N. L., Clow, F. W., Tanswell, P., Cannon, C. P., Van de Werf, F., Braunwald, E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction J Clin Pharmacol. 2000;40(5):508-15. Abstract

Gibson, C. M., Marble, S. J. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA) Clin Cardiol. 2001;24(9):577-84. Abstract

Giugliano, R. P., McCabe, C. H., Antman, E. M., Cannon, C. P., Van de Werf, F., Wilcox, R. G., Braunwald, E. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage Am Heart J. 2001;141(5):742-50. Abstract

Schweiger, M. J., Cannon, C. P., Murphy, S. A., Gibson, C. M., Cook, J. R., Giugliano, R. P., Changezi, H. U., Antman, E. M., Braunwald, E. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience) Am J Cardiol. 2001;88(8):831-6. Abstract

Srinivas, V. S., Cannon, C. P., Gibson, C. M., Antman, E. M., Greenberg, M. A., Tanasijevic, M. J., Murphy, S., de Lemos, J. A., Sokol, S., Braunwald, E., Mueller, H. S. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy Am Heart J. 2001;142(1):29-36. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Marble, S. J., Barron, H. V., Braunwald, E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation. 2002;105(16):1909-13. Abstract

Gibson, C. M., Chen, M., Angeja, B. G., Murphy, S. A., Marble, S. J., Barron, H. V., Cannon, C. P. Precordial ST-segment depression in inferior myocardial infarction is associated with slow flow in the non-culprit left anterior descending artery J Thromb Thrombolysis. 2002;13(1):12-Sep. Abstract

Murphy, S. A., Gibson, C. M., Van de Werf, F., McCabe, C. H., Cannon, C. P. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I) Am J Cardiol. 2002;90(1):51-4.

Gibson, C. M., Bigelow, B., James, D., Tepper, M. R., Murphy, S. A., Kirtane, A. J., Giugliano, R. P., Cannon, C. P., Antman, E. M. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction Am J Cardiol. 2004;94(1):108-11. Abstract